ATS 2021: Zephyr Valves Show Long-Term Benefit in Severe Emphysema
Follow-up data from the TRANSFORM study demonstrates their continued efficacy and safety
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.